Back
ESC Professional Premium Access

Mesenchymal stromal cell therapy with early tacrolimus withdrawal prevents left atrial remodelling in renal transplant recipients: an analysis of the TRITON trial

Session: Renal failure and cardiovascular disease 1
Topic: Renal Failure and Cardiovascular Disease
Speaker: Doctor M. Meucci (Rome, IT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maria Chiara Meucci

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)
3 presentations
2 followers

7 more presentations in this session

Association between global longitudinal strain and myocardial fibrosis biomarkers in patients with end-stage chronic kidney disease

Speaker: Doctor C. Ureche (Iasi, RO)

Access
Abstract
Slides
Like
Thumbnail

The effect of the location of arteriovenous fistula on the right ventricle in end stage renal disease patients indicated for hemodialysis

Speaker: Doctor S. Ali (Ismailia, EG)

Access
Abstract
Slides
Like
Thumbnail

Renal failure: a non-cardiac source of high sensitivity cardiac troponin T

Speaker: Miss A. Papachristou (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Impact of lifetime concentration of mannose on renal function: insights from mendelian randomization.

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Comparison of CT acquired valvular calcification scores in hemodialysis vs peritoneal dialysis patients undergoing open heart surgery

Speaker: Doctor C. Kanaan (Cleveland, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Renal failure and cardiovascular disease 1

Speakers: Doctor M. Meucci, Doctor C. Ureche, Doctor S. Ali, Miss A. Papachristou, Professor M. Banach...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources